Endothelial heparanase regulates heart metabolism by stimulating lipoprotein lipase secretion from cardiomyocytes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 5, 2013, Pages 894-902

  Wang, Ying ^a   Zhang, Dahai ^a   Chiu, Amy Pei Ling ^a   Wan, Andrea ^a   Neumaier, Katharina ^a   Vlodavsky, Israel ^b   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

heart; heparanase; high glucose; lipoprotein lipase; RhoA

Indexed keywords

GLUCOSE; HEPARANASE; LIPOPROTEIN LIPASE; PROTEIN KINASE C ALPHA; PROTEOHEPARAN SULFATE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME RELEASE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HYPERGLYCEMIA; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL COMMUNICATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; LIPOPROTEIN LIPASE; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; PROTEIN KINASE C-ALPHA; RATS; RATS, WISTAR; RHOA GTP-BINDING PROTEIN;

EID: 84876284290     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301309     Document Type: Article

References (43)

1. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2006;291:H1489-H1506.
2. Voshol PJ, Rensen PC, van Dijk KW, Romijn JA, Havekes LM. Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models. Biochim Biophys Acta. 2009;1791:479-485.
3. Tannock LR, Chait A. Lipoprotein-matrix interactions in macrovascular disease in diabetes. Front Biosci. 2004;9:1728-1742.
4. Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immu-nocytochemical study. Am J Physiol. 1989;256(6 pt 1):E818-E828.
5. Camps L, Reina M, Llobera M, Vilaró S, Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol. 1990;258(4 pt 1): C673-C681.
6. Pulinilkunnil T, Qi D, Ghosh S, Cheung C, Yip P, Varghese J, Abrahani A, Brownsey R, Rodrigues B. Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining. Cardiovasc Res. 2003;59:788-797.
7. Pulinilkunnil T, Abrahani A, Varghese J, Chan N, Tang I, Ghosh S, Kulpa J, Allard M, Brownsey R, Rodrigues B. Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. J Mol Cell Cardiol. 2003;35:1093-1103.
8. Severson DL, Lee M, Carroll R. Secretion of lipoprotein lipase from myocardial cells isolated from adult rat hearts. Mol Cell Biochem. 1988;79:17-24.
9. Ewart HS, Severson DL. Insulin and dexamethasone stimulation of cardiac lipoprotein lipase activity involves the actin-based cytoskeleton. Biochem J. 1999;340(pt 2):485-490.
10. Kim MS, Kewalramani G, Puthanveetil P, Lee V, Kumar U, An D, Abrahani A, Rodrigues B. Acute diabetes moderates traffcking of cardiac lipopro-tein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization. Diabetes. 2008;57:64-76.
11. Nadanaka S, Kitagawa H. Heparan sulphate biosynthesis and disease. J Biochem. 2008;144:7-14.
12. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol. 2008;9:224.
13. Couchman JR. Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol. 2010;26:89-114.
14. Kolset SO, Salmivirta M. Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci. 1999;56:857-870.
15. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem. 1992;267:20435-20443.
16. Chuang CY, Lord MS, Melrose J, Rees MD, Knox SM, Freeman C, Iozzo RV, Whitelock JM. Heparan sulfate-dependent signaling of fbro-blast growth factor 18 by chondrocyte-derived perlecan. Biochemistry. 2010;49:5524-5532.
17. Levy-Adam F, Feld S, Suss-Toby E, Vlodavsky I, Ilan N. Heparanase facilitates cell adhesion and spreading by clustering of cell surface hepa-ran sulfate proteoglycans. PLoS ONE. 2008;3:e2319.
18. Shi ZD, Abraham G, Tarbell JM. Shear stress modulation of smooth muscle cell marker genes in 2-D and 3-D depends on mechanotransduction by heparan sulfate proteoglycans and ERK1/2. PLoS ONE. 2010;5:e12196.
19. Pillarisetti S, Paka L, Sasaki A, Vanni-Reyes T, Yin B, Parthasarathy N, Wagner WD, Goldberg IJ. Endothelial cell heparanase modulation of lipo-protein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone. J Biol Chem. 1997;272:15753-15759.
20. Fux L, Ilan N, Sanderson RD, Vlodavsky I. Heparanase: busy at the cell surface. Trends Biochem Sci. 2009;34:511-519.
21. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem. 2004;279:23536-23541.
22. Cui H, Shao C, Liu Q, Yu W, Fang J, Yu W, Ali A, Ding K. Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway. Biochem J. 2011;440:273-282.
23. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci. 2004;117(pt 11):2249-2258.
24. Wang F, Kim MS, Puthanveetil P, Kewalramani G, Deppe S, Ghosh S, Abrahani A, Rodrigues B. Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid. Am J Physiol Heart Circ Physiol. 2009;296:H1108-H1116.
25. Wang Y, Puthanveetil P, Wang F, Kim MS, Abrahani A, Rodrigues B. Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes. 2011;60:2041-2050.
26. Pulinilkunnil T, An D, Ghosh S, Qi D, Kewalramani G, Yuen G, Virk N, Abrahani A, Rodrigues B. Lysophosphatidic acid-mediated augmentation of cardiomyocyte lipoprotein lipase involves actin cytoskeleton reorganization. Am J Physiol Heart Circ Physiol. 2005;288:H2802-H2810.
27. Hakoshima T, Shimizu T, Maesaki R. Structural basis of the Rho GTPase signaling. J Biochem. 2003;134:327-331.
28. Kim MS, Wang Y, Rodrigues B. Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy. Biochim Biophys Acta. 2012;1821:800-808.
29. Bassenge E, Wendt VE, Schollmeyer P, Bluemchen G, Gudbjarnason S, Bing RJ. Effect of ketone bodies on cardiac metabolism. Am J Physiol. 1965;208:162-168.
30. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279-293.
31. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207-258.
32. Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol. 1994;72:1110-1119.
33. Camps M, Castelló A, Muñoz P, Monfar M, Testar X, Palacín M, Zorzano A. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Heterogeneous response in heart, red and white muscle. Biochem J. 1992;282(pt 3): 765-772.
34. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol. 2010;7:637-647.
35. Gingis-Velitski S, Zetser A, Kaplan V, Ben-Zaken O, Cohen E, Levy-Adam F, Bashenko Y, Flugelman MY, Vlodavsky I, Ilan N. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J Biol Chem. 2004;279:44084-44092.
36. Shafat I, Vlodavsky I, Ilan N. Characterization of mechanisms involved in secretion of active heparanase. J Biol Chem. 2006;281: 23804-23811.
37. Wang F, Wang Y, Kim MS, Puthanveetil P, Ghosh S, Luciani DS, Johnson JD, Abrahani A, Rodrigues B. Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization. Cardiovasc Res. 2010;87:127-136.
38. Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N, Vlodavsky I. Proteoglycans in health and disease: new concepts for heparan-ase function in tumor progression and metastasis. FEBS J. 2010;277: 3890-3903.
39. Keum E, Kim Y, Kim J, Kwon S, Lim Y, Han I, Oh ES. Syndecan-4 regulates localization, activity and stability of protein kinase C-alpha. Biochem J. 2004;378(pt 3):1007-1014.
40. Kuriyama S, Mayor R. A role for Syndecan-4 in neural induction involving ERK-and PKC-dependent pathways. Development. 2009;136:575-584.
41. Avalos AM, Valdivia AD, Muñoz N, Herrera-Molina R, Tapia JC, Lavandero S, Chiong M, Burridge K, Schneider P, Quest AF, Leyton L. Neuronal Thy-1 induces astrocyte adhesion by engaging syndecan-4 in a cooperative interaction with alphavbeta3 integrin that activates PKCalpha and RhoA. J Cell Sci. 2009;122(pt 19):3462-3471.
42. Oh ES, Woods A, Lim ST, Theibert AW, Couchman JR. Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4, 5-bispho-sphate coordinately regulate protein kinase C activity. J Biol Chem. 1998;273:10624-10629.
43. Horowitz A, Murakami M, Gao Y, Simons M. Phosphatidylinositol-4, 5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C. Biochemistry. 1999;38:15871-15877.